| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |